P01.005 The impact of thrombocytopenia from concomitant and adjuvant temozolomide in patients with glioblastoma

BACKGROUND: Temozolomide (TMZ) administered daily with radiation therapy for six weeks, followed by adjuvant TMZ for six months is standard therapy for patients (pts) with newly diagnosed glioblastoma (GBM). Thrombocytopenia (TBP) usually appears in 10 % of patients and is responsible for treatment...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Nivet, A, Schernberg, A, Louvel, G, Dumont, S, Ammary, S, Rehalia-Blanchard, A, Clavère, P, Parker, F, Pallud, J, Dhermain, F
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Poster Presentations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144430/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.047
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller